Evodiamine ameliorates paclitaxel-induced neuropathic pain by inhibiting inflammation and maintaining mitochondrial anti-oxidant functions
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evodiamine ameliorates paclitaxel-induced neuropathic pain by inhibiting inflammation and maintaining mitochondrial anti-oxidant functions
Authors
Keywords
Neuropathic pain, Paclitaxel, Evodiamine, Inflammation, Oxidative stress, Mitochondrial dysfunction
Journal
Human Cell
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-01-30
DOI
10.1007/s13577-019-00238-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antiproliferative hydrogen sulfide releasing evodiamine derivatives and their apoptosis inducing properties
- (2018) Xu Hu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Ghrelin alleviates paclitaxel-induced peripheral neuropathy by reducing oxidative stress and enhancing mitochondrial anti-oxidant functions in mice
- (2018) Nobuyuki Ishii et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Role of Complement in a Rat Model of Paclitaxel-Induced Peripheral Neuropathy
- (2018) Jijun Xu et al. JOURNAL OF IMMUNOLOGY
- Probiotic DSF counteracts chemotherapy induced neuropathic pain
- (2018) Vanessa Castelli et al. Oncotarget
- Dexmedetomidine Protects Against Traumatic Brain Injury-Induced Acute Lung Injury in Mice
- (2018) Yuanyuan Wang et al. MEDICAL SCIENCE MONITOR
- Rapamycin alleviates proinflammatory cytokines and nociceptive behavior induced by chemotherapeutic paclitaxel
- (2018) Xiaoli Zhang et al. NEUROLOGICAL RESEARCH
- Dorsal Root Ganglion Infiltration by Macrophages Contributes to Paclitaxel Chemotherapy-Induced Peripheral Neuropathy
- (2016) Hongmei Zhang et al. JOURNAL OF PAIN
- Oxidative stress in the development, maintenance and resolution of paclitaxel-induced painful neuropathy
- (2016) Natalie A. Duggett et al. NEUROSCIENCE
- Treatment of Cancer Pain by Targeting Cytokines
- (2015) I. Vendrell et al. MEDIATORS OF INFLAMMATION
- Chemotherapy-induced peripheral neuropathy: What do we know about mechanisms?
- (2015) V.A. Carozzi et al. NEUROSCIENCE LETTERS
- Identification of Mitochondria-Targeting Anticancer Compounds by an in Vitro Strategy
- (2014) Xiang Zhang et al. ANALYTICAL CHEMISTRY
- Chemotherapy-induced neuropathy: A comprehensive survey
- (2014) N.C. Miltenburg et al. CANCER TREATMENT REVIEWS
- Nociceptive neurons regulate innate and adaptive immunity and neuropathic pain through MyD88 adapter
- (2014) Xing-Jun Liu et al. CELL RESEARCH
- Treatment with anti-TNF alpha protects against the neuropathy induced by the proteasome inhibitor bortezomib in a mouse model
- (2014) Albert Alé et al. EXPERIMENTAL NEUROLOGY
- Peptidergic intraepidermal nerve fibers in the skin contribute to the neuropathic pain in paclitaxel-induced peripheral neuropathy
- (2014) Miau-Hwa Ko et al. NEUROPEPTIDES
- Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis
- (2014) Marta Seretny et al. PAIN
- Therapy for Chemotherapy-Induced Peripheral Neuropathy—In Reply
- (2013) Ellen M. Lavoie Smith et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy
- (2012) Xiao-Min Wang et al. CYTOKINE
- Effects of mitochondrial poisons on the neuropathic pain produced by the chemotherapeutic agents, paclitaxel and oxaliplatin
- (2012) Wen Hua Xiao et al. PAIN
- Chemotherapy-induced peripheral neurotoxicity
- (2010) Guido Cavaletti et al. Nature Reviews Neurology
- Intraepidermal nerve fiber loss corresponds to the development of Taxol-induced hyperalgesia and can be prevented by treatment with minocycline
- (2010) J. Boyette-Davis et al. PAIN
- Evodiamine: A Novel Anti-Cancer Alkaloid from Evodia rutaecarpa
- (2009) Junlin Jiang et al. MOLECULES
- Progress in the Studies on Rutaecarpine
- (2008) Seung Lee et al. MOLECULES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started